Endocyte
develops small molecule drug conjugation therapies for the personalized treatment of cancer... Read moreEndocyte
develops small molecule drug conjugation therapies for the personalized treatment of cancer... Read more
CEO
Add
News
Mar 24, 2022
HealthCare Dive
Endocyte: Novartis wins FDA OK for radiopharmaceutical drug, cashing in on Endocyte deal
Mar 02, 2020
FinanzNachrichten
Endocyte: ITM expands PSMA-617 supply agreement for no-carrier-added Lutetium-177
Mar 02, 2020
firstwordpharma
Endocyte: ITM expands PSMA-617 supply agreement for no-carrier-added Lutetium-177
Apr 09, 2019
The Business Journals: Raleigh/Durham
Endocyte: Chimerix taps former Endocyte executive as new CEO
Dec 27, 2018
BioPortfolio
Endocyte: STAT Plus 2018s comeback kid Endocyte goes from nosedive to Novartis latest acquisition
Nov 15, 2018
BioPortfolio
Endocyte: Endocyte Inc ECYT Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23102018 Prices from USD $250
Nov 12, 2018
Inside INdiana Business
Endocyte: Endocyte Loss Narrows Amid Pending Acquisition
Nov 08, 2018
Market Exclusive
Endocyte: Endocyte, Inc. (NASDAQ:ECYT) Files An 8-K Results of Operations and Financial Condition
Nov 05, 2018
Indianapolis Business Journal
Endocyte: Endocyte insiders to reap millions from Novartis deal
Nov 02, 2018
4-traders
Endocyte: Monteverde & Associates PC Announces An Investigation Of Endocyte, Inc. - ECYT
Endocyte Competitors
1
2
3
4
5
6
7
8
9
10